Corrigendum: Molecular Portrait of GIST Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel

Haoran Qian,Na Yan,Xiaotong Hu,Junchang Jiang,Zhengzheng Cao,Dan Shen

DOI: https://doi.org/10.3389/fgene.2022.945357

IF: 3.7

2022-06-28

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.864499.].

genetics & heredity

What problem does this paper attempt to address?

Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients

Ping Chen,Haolin Song,Xu Wang,J. Guo,Jianfei Wang,Jianhua Zhou,Xiaohong Kang,Chaolei Jin,Yubo Cai,Zixuan Feng,Hainv Gao,Fang Lü,Lanjuan Li

DOI: https://doi.org/10.3389/fonc.2023.1170066

IF: 4.7

2023-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2022.1037742.].
Corrigendum: Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients

Xinhua Chen,Huimin Zhang,Minghao Wang,Hao Liu,Yanfeng Hu,Tian Lin,Hao Chen,Mingli Zhao,Tao Chen,Guoxin Li,Jiang Yu,Liying Zhao

DOI: https://doi.org/10.3389/fimmu.2023.1235273

IF: 7.3

2023-06-15

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783695.].

immunology
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis

Qiang Zhang,Hua Zhong,Yinchun Fan,Qian Liu,Jiancheng Song,Shengtao Yao,Fang Cao

DOI: https://doi.org/10.3389/fbioe.2020.599544

IF: 5.7

2020-10-23

Frontiers in Bioengineering and Biotechnology

Abstract:[This corrects the article DOI: 10.3389/fbioe.2020.00592.].

multidisciplinary sciences
Corrigendum to "Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technology" [ Cancer Pathog Ther. 2024;2:205-211]

Yutong Wang,Mengzhen Wang,Bin Chu,Minqiu Lu,Lei Shi,Shan Gao,Yuan Chen,Qin Yan,Na Ji,Li Bao

DOI: https://doi.org/10.1016/j.cpt.2024.09.002

2024-09-14

Abstract:[This corrects the article DOI: 10.1016/j.cpt.2023.12.004.].
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Corrigendum to “Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma” [Genes Dis 6(4) 2019 407–418]

Junling Tang,Li Zhang,Tiejun Zhou,Zhiwei Sun,Liangsheng Kong,Li Jing,Hongyun Xing,Hongyan Wu,Yongli Liu,Shixia Zhou,Jingyuan Li,Mei Chen,Fang Xu,Jirui Tang,Tao Ma,Min Hu,Dan Liu,Jing Guo,Xiaofeng Zhu,Yan Chen,Ting Ye,Jianyu Wang,Xiaoming Li,H. Rosie Xing

DOI: https://doi.org/10.1016/j.gendis.2021.06.001

2022-01-01

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2018.12.002.].

genetics & heredity,biochemistry & molecular biology
Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Wan-Xin Peng,Fei Liu,Jia-Hong Jiang,Hang Yuan,Ziqiang Zhang,Liu Yang,Yin-Yuan Mo

DOI: https://doi.org/10.1016/j.gendis.2024.101352

2024-06-15

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2022.02.014.].
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

Qiuqiang Chen,Gang Jia,Xilin Zhang,Wenxue Ma

DOI: https://doi.org/10.3389/fimmu.2024.1376045

IF: 7.3

2024-01-31

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1332057.].

immunology
Corrigendum: Alterations in cellular metabolism under different grades of glioma staging identified based on a multi-omics analysis strategy

Xianlei Yan,Jinwei Li,Yang Zhang,Cong Liang,Pengcheng Liang,Tao Li,Quan Liu,Xuhui Hui

DOI: https://doi.org/10.3389/fendo.2024.1486498

2024-09-26

Abstract:[This corrects the article DOI: 10.3389/fendo.2023.1292944.].
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Si Liu,Honglan Zhou,Gang Wang,Xin Lian

DOI: https://doi.org/10.3389/fcell.2023.1216783

IF: 5.5

2023-06-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.709490.].

cell biology,developmental biology
Corrigendum to "Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment" [Comput Struct Biotechnol J 20 (2022) 3322-3335]

Wenwen Wang,Jingjing Zhang,Yuqing Wang,Yasi Xu,Shirong Zhang

DOI: https://doi.org/10.1016/j.csbj.2023.10.048

2023-11-01

Abstract:[This corrects the article DOI: 10.1016/j.csbj.2022.06.046.].
Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Wei Wang,Bo Hu,Jiang-Jiang Qin,Jianwen Cheng,Xin Li,Mehrdad Rajaei,Jia Fan,Xin-Rong Yang,Ruiwen Zhang

DOI: https://doi.org/10.1016/j.gendis.2019.12.006

IF: 7.376

2019-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2019.06.001.].
Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Wan He,Gengpeng Lin,Chaohu Pan,Wenwen Li,Jing Shen,Yangli Liu,Hui Li,Dongfang Wu,Xuejia Lin

DOI: https://doi.org/10.3389/fgene.2022.879922

IF: 3.7

2022-03-11

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.761681.].

genetics & heredity
Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Jun Li,Sile Han,Cuiyun Zhang,Yanlin Luo,Li Wang,Ping Wang,Yi Wang,Qingxin Xia,Xiaoyan Wang,Bing Wei,Jie Ma,Hongle Li,Yongjun Guo

DOI: https://doi.org/10.3389/fonc.2021.840551

IF: 4.7

2022-01-14

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.655709.].

oncology
Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma

Minxin He,Mingrui Li,Yawen Guan,Ziyan Wan,Jie Tian,Fangshi Xu,Haibin Zhou,Mengchun Gao,Hang Bi,Tie Chong

DOI: https://doi.org/10.3389/fgene.2022.904512

IF: 3.7

2022-01-01

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2021.820154.].
Corrigendum: Targeting Myc Interacting Proteins As a Winding Path in Cancer Therapy

Yihui Zhou,Xiaomeng Gao,Yuan Meng,Bo Yang,Qiaojun He,Ji Cao

DOI: https://doi.org/10.3389/fphar.2021.785732

IF: 5.6

2021-01-01

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.748852.].
Correction To: Lipolytic Inhibitor G0S2 Modulates Glioma Stem-Like Cell Radiation Response

Yinfang Wang,Yanli Hou,Weiwei Zhang,Angel A. Alvarez,Yongrui Bai,Bo Hu,Shi-Yuan Cheng,Kun Yang,Yanxin Li,Haizhong Feng

DOI: https://doi.org/10.1186/s13046-019-1151-x

IF: 12.658

2019-01-01

Journal of Experimental & Clinical Cancer Research

Abstract:In the original publication of this article [1], the Gene Expression Omnibus (GEO) accession code GSE79772 is wrong. The correct accession code should be GSE86213.
Corrigendum to "optimization and Corroboration of the Regulatory Pathway of P42.3 Protein in the Pathogenesis of Gastric Carcinoma".

Yibin Hao,Tianli Fan,Kejun Nan

DOI: https://doi.org/10.1155/2015/606043

IF: 2.809

2015-01-01

Computational and Mathematical Methods in Medicine

Abstract:In the article “Optimization and Corroboration of the Regulatory Pathway of p42.3 Protein in the Pathogenesis of Gastric Carcinoma” [1], there was an error in the author information. The affiliations for the authors were incorrectly listed. The correct author line and affiliations are shown above.

Corrigendum: Molecular Portrait of GIST Associated With Clinicopathological Features: A Retrospective Study With Molecular Analysis by a Custom 9-Gene Targeted Next-Generation Sequencing Panel

Corrigendum: Validation of the GALAD model and establishment of a new model for HCC detection in Chinese patients

Corrigendum: Relationship between programmed death ligand 1 expression and other clinicopathological features in a large cohort of gastric cancer patients

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: Immune and Clinical Features of CD96 Expression in Glioma by in silico Analysis

Corrigendum to "Gene mutations in newly diagnosed multiple myeloma patients detected by next-generation sequencing technology" [ Cancer Pathog Ther. 2024;2:205-211]

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Corrigendum to “Identification and characterization of the cellular subclones that contribute to the pathogenesis of mantle cell lymphoma” [Genes Dis 6(4) 2019 407–418]

Corrigendum to "N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis" [Genes & Diseases 10 (2023) 554-567]

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Corrigendum: Targeting HER3 to overcome RGFR TKI resistance in NSCLC

Corrigendum: Alterations in cellular metabolism under different grades of glioma staging identified based on a multi-omics analysis strategy

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Corrigendum to "Identifies microtubule-binding protein CSPP1 as a novel cancer biomarker associated with ferroptosis and tumor microenvironment" [Comput Struct Biotechnol J 20 (2022) 3322-3335]

Corrigendum to "A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance" [genes Dis 694 (2019) 419-430].

Corrigendum: The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma

Corrigendum: Identification of BRCA1:c.5470_5477del as a Founder Mutation in Chinese Ovarian Cancer Patients

Corrigendum: A New Prognostic Risk Score: Based on the Analysis of Autophagy-Related Genes and Renal Cell Carcinoma

Corrigendum: Targeting Myc Interacting Proteins As a Winding Path in Cancer Therapy

Correction To: Lipolytic Inhibitor G0S2 Modulates Glioma Stem-Like Cell Radiation Response

Corrigendum to "optimization and Corroboration of the Regulatory Pathway of P42.3 Protein in the Pathogenesis of Gastric Carcinoma".